Literature DB >> 23452867

The OxyContin crisis: problematisation and responsibilisation strategies in addiction, pain, and general medicine journals.

Emma Whelan1, Mark Asbridge.   

Abstract

BACKGROUND: OxyContin(®) (Purdue Pharma, L.P., Stamford, CT) is now widely regarded as a drug of abuse fueling a larger opioid health crisis. While coverage in the North American press about OxyContin overwhelmingly focused upon the problems of related crime and addiction/misuse and the perspectives of law enforcement officials and police, coverage in those fields of medicine most intimately concerned with OxyContin-pain medicine and addiction medicine-was more nuanced.
METHODS: In this article, we draw upon the constructivist social problems tradition and Hunt's theory of moral regulation in a qualitative analysis of 24 medical journal articles. We compare and contrast pain medicine and addiction medicine representations of the OxyContin problem, the agents responsible for it, and proposed solutions.
RESULTS: While there are some significant differences, particularly concerning the nature of the problem and the agents responsible for it, both pain medicine and addiction medicine authors 'take responsibility' in ways that attempt to mitigate the potential appropriation of the issue by law enforcement and regulatory agencies.
CONCLUSIONS: The responses of pain medicine and addiction medicine journal articles represent strategic moves to recapture lost credibility, to retain client populations and tools necessary to their jobs, and to claim a seat at the table in responding to the OxyContin crisis.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Addiction medicine; Moral regulation; OxyContin; Pain medicine; Social problems

Mesh:

Substances:

Year:  2013        PMID: 23452867     DOI: 10.1016/j.drugpo.2013.01.007

Source DB:  PubMed          Journal:  Int J Drug Policy        ISSN: 0955-3959


  2 in total

1.  Health Care Provider Utilization of Prescription Monitoring Programs: A Systematic Review and Meta-Analysis.

Authors:  Alysia Robinson; Maria N Wilson; Jill A Hayden; Emily Rhodes; Samuel Campbell; Peter MacDougall; Mark Asbridge
Journal:  Pain Med       Date:  2021-07-25       Impact factor: 3.750

2.  Abuse potential, pharmacokinetics, pharmacodynamics, and safety of intranasally administered crushed oxycodone HCl abuse-deterrent controlled-release tablets in recreational opioid users.

Authors:  Stephen C Harris; Peter J Perrino; Ira Smith; Megan J Shram; Salvatore V Colucci; Cynthia Bartlett; Edward M Sellers
Journal:  J Clin Pharmacol       Date:  2013-12-11       Impact factor: 3.126

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.